A Study to Evaluate TRS01 Eye Drops in Participants With Active Non-infectious Anterior Uveitis (NCT04222712) | Clinical Trial Compass
CompletedPhase 1/2
A Study to Evaluate TRS01 Eye Drops in Participants With Active Non-infectious Anterior Uveitis
United States16 participantsStarted 2020-02-01
Plain-language summary
The objective of this study is to evaluate the safety of TRS01 eye drops in participants with active non-infectious anterior uveitis
.
Who can participate
Age range18 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* 18 years of age or older
* Able to provide informed consent, follow instructions and complete all required study visits for the duration of the study.
* Diagnosed with active non-infectious anterior uveitis requiring an increase or initiation of topical steroids for management of ocular inflammation.
An eligible subject must have:
* Non-infectious active anterior uveitis with anterior chamber cells Grade 2 or Grade 3, as specified per protocol.
* Must have vision ≥ 20/40 in the non-study eye.
* Use adequate birth control by men and women, if of reproductive potential and sexually active, as specified per protocol.
Exclusion Criteria:
* Any form of infectious uveitis
* Active retinitis
* Cancer or melanoma that is actively treated with immunotherapy
* Pregnancy / lactation
* Receiving specific medication/interventions as specified per protocol
What they're measuring
1
Assessment of Both Systemic and Ocular Adverse Events